TMO
50
3
DE
62
4
EFX
52
-3
EA
55
-5
HAL
50
2
CMS
58
-2
ADT
66
-8
OKE
61
8
T
53
-4
WYNN
48
2
CF
50
5
WY
48
4
GIS
49
3
ADI
66
3
OXY
42
4
DVN
35
3
TXT
78
3
CSCO
64
-3
VIX
30
-2
HCA
66
-9
TMO
50
3
DE
62
4
EFX
52
-3
EA
55
-5
HAL
50
2
CMS
58
-2
ADT
66
-8
OKE
61
8
T
53
-4
WYNN
48
2
CF
50
5
WY
48
4
GIS
49
3
ADI
66
3
OXY
42
4
DVN
35
3
TXT
78
3
CSCO
64
-3
VIX
30
-2
HCA
66
-9
Financhill
Back

Salesforce Vs. Blueprint Medicines Industry Stock Comparison

Buy
59

CRM
Salesforce

Last Price:
$272.16
Seasonality Move:
8.88%
Sell
49

BPMC
Blueprint Medicines

Last Price:
$128.39
Seasonality Move:
6.28%
Buy
59
Salesforce (CRM) is a Buy

Is Salesforce a Buy, Sell or Hold?

  • The current Salesforce [CRM] share price is $272.15. The Score for CRM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.35. The Score for BPMC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRM Stock Price Chart

What is Salesforce's stock price today?

  • The Salesforce share price today is $272.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing slight buying pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

CRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.17 Buy
Relative Strength Index (14 RSI): 53.23 Buy
Chaikin Money Flow: 236955 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (262.44 - 271.48) Buy
Bollinger Bands (100): (256.67 - 299.17) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.65 Buy
Relative Strength Index (14 RSI): 74.59 Buy
Chaikin Money Flow: 675123 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119 - 133.06) Buy
Bollinger Bands (100): (84.56 - 117) Buy

CRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 271.13 Buy
20-day SMA: 267.63 Buy
50-day SMA: 272.03 Buy
200-day SMA: 296.46 Sell
8-day EMA: 270.22 Buy
20-day EMA: 269.03 Buy
50-day EMA: 254.96 Buy
200-day EMA: 139.4 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.23 Buy
20-day SMA: 128.14 Buy
50-day SMA: 111.57 Buy
200-day SMA: 97.6 Buy
8-day EMA: 128.16 Buy
20-day EMA: 125.23 Buy
50-day EMA: 115.07 Buy
200-day EMA: 100.77 Buy

Salesforce Earnings Growth & CRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.23 per share, an increase this year of $1.83 per share, and an increase next year of $1.26 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

Salesforce Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):